Skip to main content



The U.S. Department of Health and Human Services (HHS) Office in India has provided support for over $200 million of cooperative biomedical, behavioral and social science research and public health projects implemented by HHS' technical agencies, focused in high-priority areas such as HIV/AIDS, smallpox, polio, tuberculosis, malaria, influenza, and maternal and child health, and capacity building.

Through our collaborations we are:

  • Developing new scientific knowledge
  • Creating new technology for the development of vaccines, drugs, diagnostic tools, and medical devices
  • Collaborating on the safety and efficacy of drugs, devices and food
  • Working together to control, prevent, and eliminate diseases, and
  • Training the next generation of Indian and U.S. scientists to effectively address the global health challenges of tomorrow

The benefits from HHS collaborations with India are visible today in many parts of the country, in the form of thousands of Indian scientists trained in the United States, dozens of collaborative programs, and numerous personal and institutional relationships.

back to top

The U.S. – India Health Initiative

In November 2009, Indian Prime Minister Manmohan Singh was the Obama Administration's first official state visit.  The two leaders agreed to build on existing strong ties across academia and scientific communities by advancing public health and biomedical research collaborations between the United States and India. To further these collaborations Secretary of State Clinton launched the new administration's Strategic Dialogue during her July 2009 visit to India. As a part of this, Secretary Clinton asked Secretary Sebelius of the U.S. Department of Health and Human Services (HHS) to lead the Health Initiative, a part of the overall U.S.-India Strategic Dialogue, with India's Minister of Health and Family Welfare, Shri Ghulam Nabi Azad. The Health Initiative is envisioned as an umbrella organizing mechanism for bilateral discussions between the United States and India on health collaborations and program implementation. Since the May 2010 start of the Health Initiative much progress has been made in engaging both sides of this unique collaborative opportunity.

The Health Initiative is composed of four U.S.-India Working Groups whose purpose is to share information, identify and address policy concerns, identify new technologies, share international best practices and address implementation bottlenecks that might arise in the respective areas linked to below.

The four working groups include:

back to top

Strengthening Health Systems and Services

  • Health personnel, quality services, demand generation, and financing
  • Nursing/ Paramedical Training
  • Quality Insurance and Health Informatics
  • Public Health Intervention Procedures
  • Regulatory and Policy Reform Issues
  • Centers for Excellence/ Institutes for Excellence

back to top

Infectious Diseases

  • Polio Eradication and Expanded Program on Immunization
  • Disease Surveillance – Global Disease Detection (GDD) Center
  • Field Epidemiology and Laboratory Training Program (FELTP)
  • HIV/AIDS research, prevention, care, and treatment
  • Tuberculosis and Multi-Drug Resistant TB

back to top

Non-Communicable Diseases

  • Chronic Disease research, prevention, and control
  • Cardiovascular Diseases and Diabetes
  • Mental Health
  • Aging
  • Environmental and Occupational Health (including indoor air pollution)

back to top

Maternal and Child Health

  • Research collaboration and child survival programs
  • Technical assistance, demonstration and learning, and capacity building
  • Family planning and reproductive health
  • Nutrition

back to top

Centers for Disease Control and Prevention

With staff in several Indian cities, the CDC works on areas ranging from polio eradication to technical support for the surveillance and control of a variety of infectious diseases.

Food and Drug Administration

FDA works to ensure that food and medical products (drugs and devices) exported from India to the U.S. are safe, good quality, and effective.

National Institutes of Health

NIH works to foster research collaborations with India in a wide array of infectious and non-communicable disease and other biomedical areas.